cn2c00264_si_001.pdf (1.13 MB)
Mass Spectrometry-Based Analysis of Serum N‑Glycosylation Changes in Patients with Parkinson’s Disease
journal contribution
posted on 2022-05-31, 20:11 authored by Mingming Xu, Hong Jin, Zhen Wu, Ying Han, Jing Chen, Chengjie Mao, Piliang Hao, Xumin Zhang, Chun-Feng Liu, Shuang YangIt
is urgently needed to find reliable biofluid biomarkers for
early diagnosis of Parkinson’s disease in order to achieve
better treatment. Promising biomarkers can be found in Parkinson’s
disease-related glycoproteins as aberrant protein glycosylation plays
an important role in disease progression. However, current information
on serum N-glycoproteomic changes in Parkinson’s disease is
still limited. Here, we used glycoproteomics methods, which combine
the solid-phase chemoenzymatic method, lectin affinity chromatography,
and hydrophilic interaction chromatography with high-resolution mass
spectrometry, to analyze the glycans, glycosites, and intact glycopeptides
of serum. Increased abundance of glycans containing core fucose, sialic
acid, and bisecting N-acetyl glucosamine was detected
at the overall glycan level and also at specific glycosites of glycopeptides.
Five Parkinson’s disease-associated proteins with this type
of N-glycosylation changes were also identified. We propose that the
revealed site-specific N-glycosylation changes in serum can be potential
biomarkers for Parkinson’s disease.
History
Usage metrics
Categories
Keywords
used glycoproteomics methodsphase chemoenzymatic methodoverall glycan levellectin affinity chromatographyhydrophilic interaction chromatographyachieve better treatment>- acetyl glucosamineresolution mass spectrometryfive parkinson ’parkinson ’mass spectrometryurgently neededstill limitedsialic acidrevealed siterelated glycoproteinspromising biomarkerspotential biomarkersincreased abundanceimportant roleglycosylation changesglycoproteomic changesearly diagnosiscurrent informationbased analysisassociated proteins